跳至主要内容
临床试验/NCT05011032
NCT05011032撤回不适用

Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Twin Cities of Pakistan

Aqua Medical Services (Pvt) Ltd2 个研究点 分布在 1 个国家开始时间: 2021年8月12日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Homocysteine

研究概览

简要总结

Raised plasma Homocysteine (Hcy) was 1st proposed as a cause of vascular pathology in patients with inherited disorders of Homocysteine metabolism.leading to the hypothesis that individuals with slight to moderate elevated levels of Homocysteine may have an increased hazard for vascular disease. As an amino acid with a reactive sulfhydryl group, homocysteine has been proposed to intermediate vascular inflammation and damage by stimulating oxidative stress secondary to reactive oxygen species accumulation. which in turn leads to an rise in cardiac and vascular disease risk by stimulating endothelial dysfunction, smooth muscle cell proliferation, and vascular calcification. Consistent with this hypothesis, hyperhomocysteinemia a has been associated with an increased risk for coronary heart disease (CHD), heart failure, atrial fibrillation, stroke, and mortality.

详细描述

Excess of low density lipoproteins, high blood pressure, obesity, excess of blood sugar levels, smoking and sedentary life style are the known modifiable risk factors causing cardiovascular disease specifically Coronary disease. There can be some other substances which can additionally affect the human cardiac physiology as well i.e. high levels of Homocysteine molecule in the blood. The adverse effects of this component on multiple system of human body are evidenced in the literature since 1962 involving Nervous system, brain, Renal system, Liver functioning, Venus system and endothelial system and are still under debate. This biochemical agent has a strong relevance with the physiology of cardiovascular system and causes disturbance in the arterial supply of the heart in young population.

Homocysteine has been under a lot of discussion it is an amino acid which is synthesized by the demethylation of dietary methionine. It is a highly reactive, Sulfur-containing amino acid as a by-product of metabolism of essential amino acid specifically methionine. It was proved to be a strong risk factor causing many cardiovascular diseases, neurological disturbances and other health related issues. Homocysteine has a strong relation with the diseases involving hardening of arteries and blood clots related vascular problems.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 18 and 45 years.
  • Enough ability to complete the blood sampling procedure.
  • Residents lived in the community and can walk to hospital.

排除标准

  • Participants outside the age range.
  • History of malignancy, infection and other comorbidities

结局指标

主要结局

Homocysteine

时间窗: 4th weeks

It a marker of cardiovascular diseases.

Erythrocyte sedimentation rate (ESR)

时间窗: 4th weeks

It a marker of cardiovascular diseases.

次要结局

未报告次要终点

研究者

发起方
Aqua Medical Services (Pvt) Ltd
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Mir Arif Hussain

Director

Aqua Medical Services (Pvt) Ltd

研究点 (2)

Loading locations...

相似试验